Skip to main content

Matthew Taylor

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Matthew Taylor

Matthew Taylor is recorded as Analyst at Jefferies. Matthew Taylor has spoken on 8 earnings calls across 7 companies, most recently for Shoulder Innovations, Inc. on November 5, 2026. Those appearances were for Medline Inc. (MDLN), Shoulder Innovations, Inc. (SI), Stryker Corp (SYK), Teleflex Inc (TFX), Abbott Laboratories (ABT) and 2 other companies. The companies whose calls Matthew Taylor spoke on are classified in the Healthcare sector.

Matthew Taylor on recent calls

“I have a cool question and a follow-up right after that, but I would say it's really great to see the momentum in the rep hiring and the adoption that follows it.”
Analyst — Jefferies, Shoulder Innovations Q3 2026 Earnings Call ·
“I wanted to ask you a somewhat conceptual but also pragmatic question about AI. You know, you've seen in other areas of the market and even in healthcare recently, a lot of subsectors get credit for AI and the improvements that it could bring.”
Analyst — Jefferies, Stryker's Q3 2026 Earnings Call ·
“Maybe in terms of what you're expecting from cost for the year, can you help us maybe frame the impact of any cost inflation across manufacturing and freight? maybe help us understand, like, with any margin headwind you're seeing today or something you expect in guidance for the year?”
Analyst — Jefferies, Teleflex Inc Q1 FY2026 Earnings Call ·
“I guess you made a couple of comments in the prepared remarks about a stable operating environment and utilization, and I guess I was hoping just with your broad lens, you could comment more on that because there's been debate or concern about utilization softening with things like ACA X-freeze or just the macro…”
Analyst — Jefferies, Medline Inc. Q1 FY2026 Earnings Call ·
“I was hoping that you could talk a little bit about the trends in Structural Heart and maybe within that just address what's going on in Lefty Trial Appendage Closure. not only do you have programs including the next-gen 360 which I think people are excited about but I was hoping you could comment on what you think…”
Analyst — Jefferies, Abbott Laboratories Q1 FY2026 Earnings Call ·

Affiliation history

  • Jefferies

    Analyst

    Source not stated

    Current

Company network

Recent activity